SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study

Background: In a previous pilot weight-loss study, an association was observed between baseline fasting plasma glucose (FPG) levels and the effectiveness of the Gelesis100 treatment. The aim of this subanalysis of the Gelesis Loss Of Weight (GLOW; NCT02307279) study is to further assess the associat...

詳細記述

保存先:
書誌詳細
出版年:J Endocr Soc
主要な著者: Greenway, Frank, Fujioka, Ken, Aronne, Louis, Raben, Anne, Astrup, Arne, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Apovian, Caroline, Hill, James, Kaplan, Lee, Navas-Carretero, Santiago, Martinez, J., Still, Christopher, Sannino, Alessandro, Saponaro, Cosimo, Calderon, Henry, Urban, Lorien, Chiquette, Elaine, Leider, Harry, Ron, Eyal, Zohar, Yishai, Heshmati, Hassan
フォーマット: Artigo
言語:Inglês
出版事項: Endocrine Society 2019
主題:
Adipose Tissue, Appetite, and Obesity
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552254/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB023
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料